EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches

Nuria Bara-Ledesma iD, Adrian Viteri-Noel, Monica Lopez Rodriguez iD, Konstantinos Stamatakis iD, Martin Fabregate iD, Almudena Vazquez-Santos, Vicente Gomez Del Olmo iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nuria Bara-Ledesma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Genetic Therapy, Haploinsufficiency, RNA, Messenger, Dependovirus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most rare diseases (RDs) encompass a diverse group of inherited disorders that affect millions of people worldwide. A significant proportion of these diseases are driven by functional haploinsufficiency, which is caused by pathogenic genetic variants. Currently, most treatments for RDs are limited to symptom management, emphasizing the need for therapies that directly address genetic deficiencies. Recent advancements in gene therapy, particularly with adeno-associated viruses (AAVs) and lipid nanoparticle-encapsulated messenger RNA (mRNA), have introduced promising therapeutic approaches. AAV vectors offer durable gene expression, extensive tissue tropism, and a safety profile that makes them a leading choice for gene delivery; however, limitations remain, including packaging size and immune response. In contrast, mRNA therapeutics, formulated in LNPs, facilitate transient protein expression without the risk of genomic integration, supporting repeated dosing and pharmacokinetic control, though with less long-term expression than AAVs. This review analyzes the latest developments in AAV and mRNA technologies for rare monogenic disorders, focusing on preclinical and clinical outcomes, vector design, and delivery challenges. We also address key regulatory and immunological considerations impacting therapeutic success. Together, these advancements in AAV and mRNA technology underscore a new era in RD treatment, providing innovative tools to target the genetic root of these diseases and expanding therapeutic approaches for patients who currently face limited medical options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyHaploinsufficiencyRNA, MessengerDependovirusRare DiseasesHumansAnimalsGenetic VectorsGene Transfer TechniquesNanoparticles

Stichwörter der Autor:innen

adeno-associated virus (AAV)functional haploinsufficiencygene therapymessenger RNA (mRNA)rare diseasestransgene expression

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.
  • Faculty of Medicine and Health Sciences, Universidad de Alcalá (UAH), 28805 Alcalá de Henares, Spain.
  • Department of Molecular Biology, Universidad Autónoma de Madrid, IRYCIS, 28049 Madrid, Spain.

ORCID-Profile: Nuria Bara-Ledesma, Monica Lopez Rodriguez, Konstantinos Stamatakis, Martin Fabregate, Vicente Gomez Del Olmo

Zitieren

APA

Bara-Ledesma, N., Viteri-Noel, A., Lopez Rodriguez, M., Stamatakis, K., Fabregate, M., Vazquez-Santos, A., & Gomez Del Olmo, V. (2025). Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020578

Vancouver

Bara-Ledesma N, Viteri-Noel A, Lopez Rodriguez M, Stamatakis K, Fabregate M, Vazquez-Santos A, et al. Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020578

BibTeX
@article{BaraLedesma2025,
  author = {Bara-Ledesma, Nuria and Viteri-Noel, Adrian and Lopez Rodriguez, Monica and Stamatakis, Konstantinos and Fabregate, Martin and Vazquez-Santos, Almudena and Gomez Del Olmo, Vicente},
  title = {Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020578}
}
Kostenlos starten →